A radiostereometric and clinical long-term follow-up study of the surface replacement trapeziometacarpal joint prosthesis

• Main Authors: Bart ten Brinke, Nina M. C. Mathijssen, Ian F. Blom, Lennard A. Koster, Gerald A. Kraan
• Format: Article
• Language: English
• Published: BMC 2021-02-01
• Series: BMC Musculoskeletal Disorders
• Subjects: Radiostereometry; Trapeziometacarpal joint; Trapeziometacarpal osteoarthritis; Trapeziometacarpal joint prosthesis; Migration
• Online Access: https://doi.org/10.1186/s12891-021-03957-8

Abstract Background The aim of this study was to determine long-term survival and clinical outcomes of the surface replacement trapeziometacarpal joint prosthesis (SR™TMC) and to evaluate implant migration using radiostereometric analysis (RSA). Methods In this clinical long-term follow-up study outcomes of ten patients who received the SR™TMC joint prosthesis were evaluated using DASH and Nelson scores, Visual Analogue Scale (VAS) of pain, and key pinch strength. RSA-radiographs were obtained direct postoperatively and 6 months, 1, 5 and 10 years postoperatively and were analyzed using model-based RSA software. Results During follow-up, two early revisions took place. Mean pre-operative DASH and Nelson scores were 54 (SD 15) and 54 (SD 17), improved significantly after 6 months (DASH 25 (SD 20), Nelson 75 (SD 18)) and remained excellent during long-term follow-up in all patients with a stable implant. At final follow-up, clinical scores deteriorated clearly in two patients with a loose implant in situ. Conclusions Long-term survival of the SR™TMC joint prosthesis is relatively poor. However, clinical outcomes improved significantly in the short-term and remained excellent in the long-term in those patients with a stable implant, but deteriorated clearly in case of loosening. The role of RSA in TMC joint arthroplasty is potentially valuable but needs to be further investigated. Several challenges of RSA in the TMC joint have been addressed by the authors and suggestions to optimize RSA-data are given. Trial registration This study was registered in the Netherlands Trial Register ( NL7126 ).